| Stage | PLXS | % of rev | SPSC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.3B | 100.00% | $198M | 100.00% | PLXS ×6.60 |
| Gross profit | $131M | 10.07% | $139M | 70.16% | SPSC +60.1pp |
| Operating income | $61M | 4.70% | $8M | 4.25% | PLXS +0.4pp |
| Pre-tax income | $56M | 4.33% | $10M | 5.26% | SPSC +0.9pp |
| Net income | $43M | 3.30% | $7M | 3.47% | SPSC +0.2pp |
| Stage | PLXS | SPSC | Gap · A − B |
|---|---|---|---|
| Revenue | $1.3B100.00% | $198M100.00% | PLXS ×6.60 |
| Gross profit | 10.07%$131M | 70.16%$139M | SPSC +60.1pp |
| Operating income | 4.70%$61M | 4.25%$8M | PLXS +0.4pp |
| Pre-tax income | 4.33%$56M | 5.26%$10M | SPSC +0.9pp |
| Net income |
| 3.30%$43M |
| 3.47%$7M |
| SPSC +0.2pp |
No disclosed counterparties: SPSC.
None